Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100

Revvity Inc. (RVTY) Operating cash flow

Alert me on Operating cash flow

Revvity Inc.'s operating cash flow for fiscal 2025 was $582.9M, down 7.22% from $628.3M in fiscal 2024. Over the twelve months to 30 June 2026 it was $627.6M. Over the past ten years it has ranged from $91.3M (fiscal 2023) to $1.4B (fiscal 2021); the current reading is higher than 64% of that period. Revvity Inc. ranks 13th of 52 Diagnostics & Research companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $582.9M (7.22%)
FY2024 $628.3M 588.38%
FY2023 $91.3M (86.57%)
FY2022 $679.8M (51.81%)
FY2021 $1.4B 58.12%
FY2020 $892.2M 145.46%
FY2019 $363.5M 16.86%
FY2018 $311.0M 7.83%
FY2017 $288.5M (17.73%)
FY2016 $350.6M 22.12%

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $191.9M 66.57%
Mar 2026 $115.2M (36.67%)
Dec 2025 $182.0M 31.38%
Sep 2025 $138.5M 3.11%
42 more quarters

Against its own ten years

Low $91.3M High $1.4B
Ten-year median $363.5M
Current reading's percentile 64

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on RVTY